Prediction of Ifosfamide/Mesna associated encephalopathy
- 1 July 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (7) , 815-819
- https://doi.org/10.1016/0277-5379(86)90368-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- IFOSFAMIDE/MESNA AND ENCEPHALOPATHYThe Lancet, 1985
- ENCEPHALOPATHY ASSOCIATED WITH IFOSPHAMIDE/MESNA THERAPYThe Lancet, 1985
- Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patientsCancer Treatment Reviews, 1983
- High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trialCancer Treatment Reviews, 1983
- Clinical overview of mesnaCancer Treatment Reviews, 1983
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)European Journal of Cancer and Clinical Oncology, 1982
- Central nervous side effects following ifosfamide monotherapy of advanced renal carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1981
- CONTROLLED CLINICAL STUDIES WITH AN ANTIDOTE AGAINST THE UROTOXICITY OF OXAZAPHOSPHORINES - PRELIMINARY-RESULTS1979
- Measures of Association for Cross Classifications. II: Further Discussion and ReferencesJournal of the American Statistical Association, 1959
- Measures of Association for Cross ClassificationsJournal of the American Statistical Association, 1954